SYNTHESIS AND RESOLUTION OF (+/-)-7-CHLORO-8-HYDROXY-1-(3'-IODOPHENYL)-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE (TISCH) - A HIGH-AFFINITY AND SELECTIVE IODINATED LIGAND FOR CNS D1 DOPAMINE RECEPTOR

被引:35
作者
CHUMPRADIT, S [1 ]
KUNG, MP [1 ]
BILLINGS, JJ [1 ]
KUNG, HF [1 ]
机构
[1] UNIV PENN,DEPT RADIOL,PHILADELPHIA,PA 19104
关键词
D O I
10.1021/jm00107a002
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and resolution of (+/-)-7-chloro-8-hydroxy-1-(3'-iodophenyl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine, (+/-)-TISCH (8) has been achieved by resolution of intermediate 4, the O-methoxyl, 3'-bromo derivative, as the diastereomeric camphor sulfonate salt. The final products, R-(+)-8 and S-(-)-8, were prepared by treatment of R-(+)- or S-(-)-7, the 3'-tributyltin intermediates, with iodine in chloroform, followed by O-demethylation. By using HPLC with a chiral column, the optical purity (> 99%) of the intermediates and the final compounds was determined. Radioiodination was achieved by an iodo-destannylation reaction with sodium [I-125]iodide and hydrogen peroxide. As expected, the R-(+)-[I-125]-8 (the active isomer) displayed high affinity and selectivity to the CNS D-1 receptor in rat striatum tissue preparation (K(d) = 0.205 nM). The rank order of potency was as follows: SCH-23390 (1a) > (+/-)-8 > (+)-butaclamol > spiperone, WB4101 > dopamine, 5-HT. After an iv injection, the R-(+)-[I-125]-8 penetrated the blood-brain barrier with ease and displayed specific regional distribution corresponding to the D-1 receptor density, while the S-(-)-[I-125]-8 showed no specific uptake. The data suggest that the ligand may be useful as a pharmacological tool for characterizing the D-1 dopamine receptor. When labeled with I-123, this ligand is a potential agent for in vivo imaging of CNS D-1 dopamine receptor.
引用
收藏
页码:877 / 883
页数:7
相关论文
共 40 条
  • [1] ALAVI A, 1989, YB NUCLEAR MED, pR13
  • [2] SOME ATYPICAL NEUROLEPTICS INHIBIT [H-3] SCH 23390 BINDING INVIVO
    ANDERSEN, PH
    NIELSEN, EB
    GRONVALD, FC
    BRAESTRUP, C
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 120 (01) : 143 - 144
  • [3] CLINICAL IMPORTANCE OF D-1 AND D-2 RECEPTORS
    BEAULIEU, M
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (03) : 402 - 406
  • [4] SYNTHESIS AND RECEPTOR AFFINITIES OF SOME CONFORMATIONALLY RESTRICTED ANALOGS OF THE DOPAMINE D1 SELECTIVE LIGAND (5R)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL
    BERGER, JG
    CHANG, WK
    CLADER, JW
    HOU, D
    CHIPKIN, RE
    MCPHAIL, AT
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (08) : 1913 - 1921
  • [5] [I-125] +/-FISCH - A NEW CNS D-1 DOPAMINE RECEPTOR IMAGING LIGAND
    BILLINGS, J
    KUNG, MP
    CHUMPRADIT, S
    PAN, S
    KUNG, HF
    [J]. LIFE SCIENCES, 1989, 45 (08) : 711 - 718
  • [6] BILLINGS J, 1989, Journal of Nuclear Medicine, V30, P830
  • [7] BOYSON SJ, 1986, J NEUROSCI, V6, P3177
  • [8] METHODS FOR THE DETERMINATION OF THE SPECIFIC RADIOACTIVITY OF RADIOLIGANDS
    BURGISSER, E
    [J]. JOURNAL OF RECEPTOR RESEARCH, 1984, 4 (1-6): : 357 - 369
  • [9] CHIPKIN RE, 1988, J PHARMACOL EXP THER, V247, P1093
  • [10] (+/-)-7-CHLORO-8-HYDROXY-1-(4'-[I-125]IODOPHENYL)-3-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE - A POTENTIAL CNS D-1 DOPAMINE RECEPTOR IMAGING AGENT
    CHUMPRADIT, S
    KUNG, HF
    BILLINGS, J
    KUNG, MP
    PAN, S
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (07) : 1431 - 1435